Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a Glucagon-like-peptide-1 Agonist and Restrictive vs. Liberal Oxygen Supply in Patients Undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement - a 2-by-2 Factorial Designed, Randomized Clinical Study

NCT02673931 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT02673931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a Glucagon-like-peptide-1 Agonist and Restrictive vs. Liberal Oxygen Supply in Patients Undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement - a 2-by-2 Factorial Designed, Randomized Clinical Study
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 29, 2016
Completion date
September 30, 2024
Enrollment
1,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, brain injury, coronary disease, renal failure, shock, cardiogenic, stroke